‌

US Patent 9957250 Compounds and uses thereof for the modulation of hemoglobin

Patent 9957250 was granted and assigned to Global Blood Therapeutics on May, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Global Blood Therapeutics

0

Current Assignee

Global Blood Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jason R. Harris0

Zhe Li0

Brian W. Metcalf0

Stephen L. Gwaltney, II0

Date of Patent

May 1, 2018

0

Patent Application Number

149808900

Date Filed

December 28, 2015

0

Patent Citations Received

US Patent 11944612 Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde

0

Patent Primary Examiner

0

Patent abstract

Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9957250 Compounds and uses thereof for the modulation of hemoglobin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.